As more individuals seek health insights from AI platforms like ChatGPT, the demand for innovative healthcare solutions is on the rise. KJ Dhaliwal, who previously sold the South Asian dating app Dil Mil for $50 million, has leveraged his experiences to address the inefficiencies in the U.S. healthcare system.
In May 2024, Dhaliwal launched Lotus Health AI, a revolutionary primary care service that operates around the clock and offers support in 50 languages. Recently, the company announced a successful $35 million Series A funding round, co-led by CRV and Kleiner Perkins, bringing its total funding to $41 million.
While many are already turning to AI for health consultations, Lotus Health goes beyond mere conversations. It provides comprehensive medical care, including diagnoses, prescriptions, and referrals to specialists.
Essentially, Lotus is creating an AI-driven medical practice with licenses to operate in all 50 states, malpractice insurance, and systems compliant with HIPAA regulations, ensuring complete access to patient records.
The distinguishing feature of Lotus is that the majority of patient interactions are managed by AI, which is designed to emulate the questioning style of a physician.
Recognizing the potential for inaccuracies in AI, the company employs board-certified doctors from esteemed institutions like Stanford and Harvard to review diagnoses, lab orders, and prescriptions, ensuring a thorough vetting process.
Lotus is aware of the limitations of virtual care and directs patients with urgent health concerns to the nearest urgent care facilities or emergency rooms. For cases requiring physical examinations, the platform refers patients to in-person healthcare providers.
Delegating significant aspects of medical decision-making to AI represents a bold initiative, especially given the regulatory complexities in healthcare. Physicians are limited to treating patients in states where they hold valid licenses.
Saar Gur, a general partner at CRV who led the funding round, acknowledges the challenges but believes that the advancements in telemedicine and AI position Lotus to overcome many existing barriers.
"It's a bold move," Gur stated, highlighting the potential for Lotus to transform the primary care landscape significantly.
In a time when there is a notable shortage of primary care physicians, Lotus claims it can accommodate ten times the number of patients compared to traditional practices, even with a 15-minute limit per visit.
Though Lotus is not the only company developing AI healthcare solutions, it distinguishes itself by currently offering its services entirely free of charge. Future business strategies may involve sponsored content or subscription models, but the immediate focus remains on enhancing product offerings and expanding its patient base.